Moody Aldrich Partners LLC Cytokinetics Inc Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

A detailed history of Moody Aldrich Partners LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 46,731 shares of CYTK stock, worth $2.41 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
46,731
Previous 69,905 33.15%
Holding current value
$2.41 Million
Previous $3.79 Million 34.86%
% of portfolio
0.49%
Previous 0.8%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$51.22 - $60.16 $1.19 Million - $1.39 Million
-23,174 Reduced 33.15%
46,731 $2.47 Million
Q2 2024

Jul 23, 2024
SELL
$47.86 - $75.05 $143,197 - $224,549
-2,992 Reduced 4.1%
69,905 $3.79 Million
Q1 2024

Apr 29, 2024
BUY
$63.75 - $108.06 $2.74 Million - $4.65 Million
43,026 Added 144.04%
72,897 $5.11 Million
Q4 2023

Jan 25, 2024
SELL
$26.88 - $83.49 $1.74 Million - $5.39 Million
-64,577 Reduced 68.37%
29,871 $2.49 Million
Q3 2023

Nov 07, 2023
BUY
$29.46 - $36.61 $152,367 - $189,346
5,172 Added 5.79%
94,448 $2.78 Million
Q2 2023

Jul 28, 2023
SELL
$32.62 - $40.75 $8,807 - $11,002
-270 Reduced 0.3%
89,276 $2.91 Million
Q1 2023

Apr 27, 2023
SELL
$33.36 - $45.71 $109,654 - $150,248
-3,287 Reduced 3.54%
89,546 $3.15 Million
Q4 2022

Jan 23, 2023
SELL
$35.77 - $51.11 $80,732 - $115,355
-2,257 Reduced 2.37%
92,833 $0
Q3 2022

Oct 18, 2022
SELL
$38.54 - $54.52 $1.7 Million - $2.4 Million
-44,086 Reduced 31.68%
95,090 $4.61 Million
Q2 2022

Jul 18, 2022
BUY
$33.93 - $48.92 $1.51 Million - $2.18 Million
44,620 Added 47.19%
139,176 $5.47 Million
Q1 2022

May 10, 2022
BUY
$29.74 - $46.0 $297,608 - $460,322
10,007 Added 11.84%
94,556 $3.48 Million
Q4 2021

Feb 02, 2022
SELL
$34.35 - $46.38 $536,924 - $724,965
-15,631 Reduced 15.6%
84,549 $3.85 Million
Q3 2021

Oct 29, 2021
BUY
$18.54 - $35.74 $1.86 Million - $3.58 Million
100,180 New
100,180 $3.58 Million

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.85B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email